At the Radiological Society of North America (RSNA) 2025 conference, Siemens Healthineers showcased its latest advancements in medical imaging technology, with a strong emphasis on artificial intelligence (AI) and interventional radiology. The company’s exhibit highlighted its commitment to improving patient care and outcomes through innovative solutions.
In the realm of AI, Siemens introduced its new AI-powered imaging software, which enables faster and more accurate diagnoses. The software utilizes machine learning algorithms to analyze medical images and detect abnormalities, such as tumors or vascular diseases. This technology has the potential to significantly enhance the diagnostic process, allowing radiologists to make more informed decisions and provide better patient care.
Siemens also showcased its latest advancements in interventional radiology, including its Artis icono angiography system. This system features advanced imaging capabilities, such as 3D reconstruction and real-time imaging, which enable clinicians to perform complex procedures with greater precision and accuracy. The Artis icono also includes AI-powered features, such as automated dose reduction and image enhancement, which can help reduce radiation exposure and improve image quality.
Another key area of focus for Siemens at RSNA 2025 was its Magnetom portfolio of magnetic resonance imaging (MRI) systems. The company introduced its new Magnetom Lumina 3T MRI system, which features advanced AI-powered imaging capabilities and a more patient-friendly design. The system’s AI algorithms enable faster and more accurate image acquisition, while its ergonomic design provides greater patient comfort and reduces the need for repeat scans.
In addition to its product showcases, Siemens also highlighted its partnership with several healthcare organizations to develop new AI-powered imaging solutions. These partnerships aim to leverage the power of AI to improve patient outcomes and reduce healthcare costs. For example, Siemens is working with the University of California, San Francisco (UCSF) to develop an AI-powered imaging platform for detecting and diagnosing cardiovascular disease.
Overall, Siemens’ exhibit at RSNA 2025 demonstrated the company’s commitment to innovation and its focus on improving patient care through advanced medical imaging technologies. With its emphasis on AI, interventional radiology, and MRI, Siemens is well-positioned to shape the future of medical imaging and improve outcomes for patients around the world. By leveraging the power of AI and other advanced technologies, Siemens is helping to transform the field of radiology and enable clinicians to provide better care for their patients.